50
Participants
Start Date
April 30, 2015
Primary Completion Date
November 30, 2019
Study Completion Date
April 29, 2020
metyrapone
Single arm study
San Luigi Gonzaga Hospital, University of Turin, Orbassano
State health center, Budapest
Charité Berlin, Berlin
University hospital Antwerp, Antwerp
CHU Erasme, Brussels
University hospital Saint Luc, Brussels
CHU Liège, Liège
Universitätsklinikum Essen, Essen
Munich university, Munich
University hospital Wuerzburg, Würzburg
Semmelweis Egyetem II. Belgyógyászati Klinika, Budapest
University Debrecen, Debrecen
University of Pecs, Pécs
University of Szeged, Szeged
Grande Ospedale Metropolitano Niguarda, Milan
Ospedale San Luca IRCCS Istituto Auxologico Italiano, Milan
S. Giuseppe Hospital, Milan
Federico II University, Naples
University of Padova, Padua
University of Turin, Turin
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
University Hospital, Krakow
University Clinical Hospital, Wroclaw
Institutul National de Endocrinologie 'C.I Parhon' - Endocrinologie II, Bucharest
Institutul National de Endocrinologie 'C.I Parhon' - Endocrinologie VI, Bucharest
Spitalul Universitar de Urgenta Militar Central 'Dr Carol Davila', Bucharest
Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca
S.C Centrul Clinic Mediquest SRL, Sângeorgiu de Mureş
Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu
Spitalul Clinic Judetean Mures, Târgu Mureş
University hospital clinic of Barcelona, Barcelona
Hospital Universitario La Ribera, Valencia
Ankara Numune Training and Research Hospital, Ankara
Dokuz Eylul UMF, Izmir
Ondokuz Mayıs University Medical Faculty, Samsun
Karadeniz Teknik University, Trabzon
Lead Sponsor
HRA Pharma
INDUSTRY